Mast Cell Leukemia — Trials

Mast Cell Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 33%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05219266	Managed Access Programs for PKC412, Midostaurin	no longer available	—	—	Novartis PharmaceuticalsINDUSTRY	0	Jun 28, 2024	clinicaltrials

Data updated 22 days agoSource updated Jun 28, 2024source: clinicaltrials